Who owns CRVS? 13F holders and whale ownership
CRVS is tracked across public portfolios in Whale Analyzer. This page answers who owns CRVS, which top funds are buying CRVS, aggregate disclosed value, and recent position changes based on public data. Samuel Isaly is the largest reported holder at $105M; the top five funds control 100.0% of reported ownership; institutions were net buying last quarter (2 increased, 0 reduced); the stock trades above the aggregate whale cost basis of $11.24. Top tracked holders include Samuel Isaly, Joseph Edelman, and Peter Kolchinsky.
Continue to the live CRVS dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Samuel Isaly 13F portfolio OrbiMed Advisors holdings | $104.8M | 7.2M | Held |
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $33.5M | 2.3M | Increased |
| Peter Kolchinsky 13F portfolio RA Capital Management holdings | $6.6M | 450.0K | New |
Ownership concentration
Reported ownership of CRVS is highly concentrated across tracked institutions.
- Single largest holder: 72.3% of reported ownership
- Top 5 holders: 100.0%
- Top 10 holders: 100.0%
Whale activity this quarter
Across 3 tracked institutions, 2 increased, 1 held. Net positioning is net buying.
- Samuel Isaly — OrbiMed Advisors ($104.8M) (→ 0.0% qoq shares) · avg cost $11.58
- Joseph Edelman — Perceptive Advisors ($33.5M) (▲ 231.1% qoq shares) · avg cost $9.48
- Peter Kolchinsky — RA Capital Management ($6.6M) · avg cost $14.63
Whale cost basis vs current price
The aggregate tracked cost basis is $11.24 versus a current price of $13.49, so CRVS trades above its cost basis (+20.1%). Average unrealized P&L across tracked holders: 6%.
Sector positioning — Health Care
CRVS sits within the Health Care sector alongside 221 other tracked names. Compare whale ownership across peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live CRVS dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- EWTX whale holders — EDGEWISE THERAPEUTICS INC
- ELVN whale holders — ENLIVEN THERAPEUTICS INC
- LLY whale holders — ELI LILLY & CO
- SVA whale holders — SINOVAC BIOTECH LTD
- BSX whale holders — BOSTON SCIENTIFIC CORP
- SION whale holders — SIONNA THERAPEUTICS INC
- AZN whale holders — ASTRAZENECA PLC
- MYGN whale holders — MYRIAD GENETICS INC
Learn more in Whale Analyzer Academy
Deepen your read on CRVS with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns CRVS stock?
Whale Analyzer tracks 3 public institutional holders of CRVS with a combined reported value of $144.9M. See the holder table above for the largest tracked positions.
Which top funds are buying CRVS?
Tracked institutions were net buying last quarter — 2 increased, 1 held. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is CRVS ownership?
The top five tracked holders report 100.0% of aggregate ownership.
Is CRVS above or below the whale cost basis?
The aggregate tracked cost basis is $11.24 versus a current price of $13.49 (+20.1%).
What does 13F ownership mean for CRVS?
Use the interactive CRVS dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.